ANESTIBIDABO SLP
Company details
- Active NIF/CIF: B65805228
-
-
-
-
Address: 248, Carrer de Muntaner, 1, 08011 Barcelona, España See in map
-
-
Featured products:
More information on ANESTIBIDABO SLP
-
VELAURE ALVAREZ MANUEL ANGELConsejeroAppointment: 23/08/2012
-
VELAURE ALVAREZ MANUEL ANGELConsejero delegadoAppointment: 23/08/2012
-
FOSSAS ESPADA MARIA CARMENConsejeroAppointment: 23/08/2012
-
FOSSAS ESPADA MARIA CARMENConsejero delegadoAppointment: 23/08/2012
-
CAHISA MUR MANUELConsejeroAppointment: 23/08/2012
-
CAHISA MUR MANUELConsejero delegadoAppointment: 23/08/2012
-
CAHISA MUR MANUELPresidenteAppointment: 23/08/2012
-
SANCHEZ MARTIN MARCOSConsejeroAppointment: 23/08/2012
-
SANCHEZ MARTIN MARCOSConsejero delegadoAppointment: 23/08/2012
-
SANCHEZ MARTIN MARCOSSecretarioAppointment: 23/08/2012
Other information
The CIF assigned to ANESTIBIDABO SLP is B65805228, and its current business status is active. The company is engaged in economic activities classified under the CNAE 8610 - Hospital activities, while its SIC 8099 - Servicios sanitarios y similares is also applicable. Regarding personnel, ANESTIBIDABO SLP employs approximately Between 1 and 9 employees and generates an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Barcelona and has a total of 10 registered positions. The latest announcement of ANESTIBIDABO SLP in the Borme was published on 28/04/2017, and its most recent ordinary annual accounts deposit is from the year 2020. To obtain contact information for ANESTIBIDABO SLP, such as telephone number, postal address, or website, you can visit the Company Data module. If you wish to obtain more details about ANESTIBIDABO SLP, you can review one of our available financial reports, examine the company's Annual Accounts, or check for any registered defaults in the RAI delinquency file. The financial, business, and legal information provided about ANESTIBIDABO SLP is official and updated daily.
Do you want to know more about ANESTIBIDABO SLP??
Find out more about this company by consulting these reports: